• Je něco špatně v tomto záznamu ?

Implementation of effect biomarkers in human biomonitoring studies: A systematic approach synergizing toxicological and epidemiological knowledge

A. Rodríguez-Carrillo, V. Mustieles, E. Salamanca-Fernández, A. Olivas-Martínez, B. Suárez, L. Bajard, K. Baken, L. Blaha, EC. Bonefeld-Jørgensen, S. Couderq, SC. D'Cruz, JB. Fini, E. Govarts, C. Gundacker, AF. Hernández, M. Lacasaña, F. Laguzzi,...

. 2023 ; 249 (-) : 114140. [pub] 20230224

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23003642

Human biomonitoring (HBM) studies have highlighted widespread daily exposure to environmental chemicals. Some of these are suspected to contribute to adverse health outcomes such as reproductive, neurological, and metabolic disorders, among other developmental and chronic impairments. One of the objectives of the H2020 European Human Biomonitoring Initiative (HBM4EU) was the development of informative effect biomarkers for application in a more systematic and harmonized way in large-scale European HBM studies. The inclusion of effect biomarkers would complement exposure data with mechanistically-based information on early and late adverse effects. For this purpose, a stepwise strategy was developed to identify and implement a panel of validated effect biomarkers in European HBM studies. This work offers an overview of the complete procedure followed, from comprehensive literature search strategies, selection of criteria for effect biomarkers and their classification and prioritization, based on toxicological data and adverse outcomes, to pilot studies for their analytical, physiological, and epidemiological validation. We present the example of one study that demonstrated the mediating role of the effect biomarker status of brain-derived neurotrophic factor BDNF in the longitudinal association between infant bisphenol A (BPA) exposure and behavioral function in adolescence. A panel of effect biomarkers has been implemented in the HBM4EU Aligned Studies as main outcomes, including traditional oxidative stress, reproductive, and thyroid hormone biomarkers. Novel biomarkers of effect, such as DNA methylation status of BDNF and kisspeptin (KISS) genes were also evaluated as molecular markers of neurological and reproductive health, respectively. A panel of effect biomarkers has also been applied in HBM4EU occupational studies, such as micronucleus analysis in lymphocytes and reticulocytes, whole blood comet assay, and malondialdehyde, 8-oxo-2'-deoxyguanosine and untargeted metabolomic profile in urine, to investigate, for example, biological changes in response to hexavalent chromium Cr(VI) exposure. The use of effect biomarkers in HBM4EU has demonstrated their ability to detect early biological effects of chemical exposure and to identify subgroups that are at higher risk. The roadmap developed in HBM4EU confirms the utility of effect biomarkers, and support one of the main objectives of HBM research, which is to link exposure biomarkers to mechanistically validated effect and susceptibility biomarkers in order to better understand the public health implications of human exposure to environmental chemicals.

Biomedical Research Center 18012 Granada Spain

Centre for Arctic Health and Molecular Epidemiology Department of Public Health Aarhus University Denmark

Consortium for Biomedical Research in Epidemiology and Public Health Spain

Department of Biomedical Sciences and Toxicological Center University of Antwerp Belgium

Department of Environmental Health Norwegian Institute of Public Health Oslo Norway

Department of Legal Medicine and Toxicology University of Granada School of Medicine Granada Spain

Department of Radiology and Physical Medicine School of Medicine University of Granada 18016 Granada Spain

Environment Agency Austria Vienna Austria

European University Cyprus Nicosia Cyprus

German Federal Institute for Risk Assessment Max Dohrn Straße 8 10 10589 Berlin Germany

Greenland Centre for Health Research University of Greenland Nuuk Greenland

Institute of Environmental Medicine Karolinska Institute Stockholm Sweden

Institute of Medical Genetics Medical University of Vienna Waehringer Strasse 10 A 1090 Vienna Austria

National Food Institute Technical University of Denmark 2800 Kgs Lyngby Denmark

National Institute of Health Doutor Ricardo Jorge NOVA Medical School FCM Universidade Nova de Lisboa Av Padre Cruz 1649 016 Lisbon Portugal

Physiologie Moléculaire et Adaptation Département Adaptation du Vivant UMR 7221 MNHN CNRS Muséum National d'Histoire Naturelle Paris 75005 France

RECETOX Faculty of Science Masaryk University Kamenice 5 CZ62500 Brno Czech Republic

The National Research Centre for the Working Environment Copenhagen Denmark

Univ Rennes EHESP Inserm Irset UMR_S 1085 F 35000 Rennes France

VITO Health Flemish Institute for Technological Research Mol Belgium

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003642
003      
CZ-PrNML
005      
20230425140755.0
007      
ta
008      
230418s2023 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijheh.2023.114140 $2 doi
035    __
$a (PubMed)36841007
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Rodríguez-Carrillo, Andrea $u Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain
245    10
$a Implementation of effect biomarkers in human biomonitoring studies: A systematic approach synergizing toxicological and epidemiological knowledge / $c A. Rodríguez-Carrillo, V. Mustieles, E. Salamanca-Fernández, A. Olivas-Martínez, B. Suárez, L. Bajard, K. Baken, L. Blaha, EC. Bonefeld-Jørgensen, S. Couderq, SC. D'Cruz, JB. Fini, E. Govarts, C. Gundacker, AF. Hernández, M. Lacasaña, F. Laguzzi, B. Linderman, M. Long, H. Louro, C. Neophytou, A. Oberemn, S. Remy, AK. Rosenmai, AT. Saber, G. Schoeters, MJ. Silva, F. Smagulova, M. Uhl, AM. Vinggaard, U. Vogel, M. Wielsøe, N. Olea, MF. Fernández
520    9_
$a Human biomonitoring (HBM) studies have highlighted widespread daily exposure to environmental chemicals. Some of these are suspected to contribute to adverse health outcomes such as reproductive, neurological, and metabolic disorders, among other developmental and chronic impairments. One of the objectives of the H2020 European Human Biomonitoring Initiative (HBM4EU) was the development of informative effect biomarkers for application in a more systematic and harmonized way in large-scale European HBM studies. The inclusion of effect biomarkers would complement exposure data with mechanistically-based information on early and late adverse effects. For this purpose, a stepwise strategy was developed to identify and implement a panel of validated effect biomarkers in European HBM studies. This work offers an overview of the complete procedure followed, from comprehensive literature search strategies, selection of criteria for effect biomarkers and their classification and prioritization, based on toxicological data and adverse outcomes, to pilot studies for their analytical, physiological, and epidemiological validation. We present the example of one study that demonstrated the mediating role of the effect biomarker status of brain-derived neurotrophic factor BDNF in the longitudinal association between infant bisphenol A (BPA) exposure and behavioral function in adolescence. A panel of effect biomarkers has been implemented in the HBM4EU Aligned Studies as main outcomes, including traditional oxidative stress, reproductive, and thyroid hormone biomarkers. Novel biomarkers of effect, such as DNA methylation status of BDNF and kisspeptin (KISS) genes were also evaluated as molecular markers of neurological and reproductive health, respectively. A panel of effect biomarkers has also been applied in HBM4EU occupational studies, such as micronucleus analysis in lymphocytes and reticulocytes, whole blood comet assay, and malondialdehyde, 8-oxo-2'-deoxyguanosine and untargeted metabolomic profile in urine, to investigate, for example, biological changes in response to hexavalent chromium Cr(VI) exposure. The use of effect biomarkers in HBM4EU has demonstrated their ability to detect early biological effects of chemical exposure and to identify subgroups that are at higher risk. The roadmap developed in HBM4EU confirms the utility of effect biomarkers, and support one of the main objectives of HBM research, which is to link exposure biomarkers to mechanistically validated effect and susceptibility biomarkers in order to better understand the public health implications of human exposure to environmental chemicals.
650    _2
$a mladiství $7 D000293
650    _2
$a lidé $7 D006801
650    12
$a biologický monitoring $7 D000079687
650    12
$a mozkový neurotrofický faktor $7 D019208
650    _2
$a biologické markery $7 D015415
650    _2
$a monitorování životního prostředí $x metody $7 D004784
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mustieles, Vicente $u Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain
700    1_
$a Salamanca-Fernández, Elena $u Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain. Electronic address: esalamanca@ugr.es
700    1_
$a Olivas-Martínez, Alicia $u Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain
700    1_
$a Suárez, Beatriz $u Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain
700    1_
$a Bajard, Lola $u RECETOX, Faculty of Science, Masaryk University, Kamenice 5, CZ62500, Brno, Czech Republic
700    1_
$a Baken, Kirsten $u VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
700    1_
$a Blaha, Ludek $u RECETOX, Faculty of Science, Masaryk University, Kamenice 5, CZ62500, Brno, Czech Republic
700    1_
$a Bonefeld-Jørgensen, Eva Cecilie $u Centre for Arctic Health & Molecular Epidemiology, Department of Public Health Aarhus University, Denmark; Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland
700    1_
$a Couderq, Stephan $u Physiologie Moléculaire et Adaptation, Département "Adaptation du Vivant", UMR 7221 MNHN/CNRS, Muséum National d'Histoire Naturelle, Paris, 75005, France
700    1_
$a D'Cruz, Shereen Cynthia $u Univ Rennes, EHESP, Inserm, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000, Rennes, France
700    1_
$a Fini, Jean-Baptiste $u Physiologie Moléculaire et Adaptation, Département "Adaptation du Vivant", UMR 7221 MNHN/CNRS, Muséum National d'Histoire Naturelle, Paris, 75005, France
700    1_
$a Govarts, Eva $u VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
700    1_
$a Gundacker, Claudia $u Institute of Medical Genetics, Medical University of Vienna, Waehringer Strasse 10, A-1090, Vienna, Austria
700    1_
$a Hernández, Antonio F $u Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain; Department of Legal Medicine and Toxicology, University of Granada School of Medicine, Granada, Spain
700    1_
$a Lacasaña, Marina $u Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain; Department of Legal Medicine and Toxicology, University of Granada School of Medicine, Granada, Spain
700    1_
$a Laguzzi, Federica $u Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
700    1_
$a Linderman, Birgitte $u Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
700    1_
$a Long, Manhai $u Centre for Arctic Health & Molecular Epidemiology, Department of Public Health Aarhus University, Denmark; Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland
700    1_
$a Louro, Henriqueta $u National Institute of Health Doutor Ricardo Jorge (INSA), Human Genetics Department, Toxicogenomics and Human Health (ToxOmics), NOVA Medical School/FCM, Universidade Nova de Lisboa, Av. Padre Cruz, 1649-016, Lisbon, Portugal
700    1_
$a Neophytou, Christiana $u European University Cyprus, Nicosia, Cyprus
700    1_
$a Oberemn, Axel $u German Federal Institute for Risk Assessment, Max-Dohrn-Straße 8-10, 10589, Berlin, Germany
700    1_
$a Remy, Sylvie $u VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
700    1_
$a Rosenmai, Anna Kjerstine $u National Food Institute, Technical University of Denmark, 2800 Kgs, Lyngby, Denmark
700    1_
$a Saber, Anne Thoustrup $u The National Research Centre for the Working Environment, Copenhagen, Denmark
700    1_
$a Schoeters, Greet $u VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium; Department of Biomedical Sciences and Toxicological Center, University of Antwerp, Belgium
700    1_
$a Silva, Maria Joao $u National Institute of Health Doutor Ricardo Jorge (INSA), Human Genetics Department, Toxicogenomics and Human Health (ToxOmics), NOVA Medical School/FCM, Universidade Nova de Lisboa, Av. Padre Cruz, 1649-016, Lisbon, Portugal
700    1_
$a Smagulova, Fatima $u Univ Rennes, EHESP, Inserm, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000, Rennes, France
700    1_
$a Uhl, Maria $u Environment Agency Austria (EAA), Vienna, Austria
700    1_
$a Vinggaard, Anne Marie $u National Food Institute, Technical University of Denmark, 2800 Kgs, Lyngby, Denmark
700    1_
$a Vogel, Ulla $u National Food Institute, Technical University of Denmark, 2800 Kgs, Lyngby, Denmark; The National Research Centre for the Working Environment, Copenhagen, Denmark
700    1_
$a Wielsøe, Maria $u Centre for Arctic Health & Molecular Epidemiology, Department of Public Health Aarhus University, Denmark
700    1_
$a Olea, Nicolás $u Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain
700    1_
$a Fernández, Mariana F $u Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain. Electronic address: marieta@ugr.es
773    0_
$w MED00005700 $t International journal of hygiene and environmental health $x 1618-131X $g Roč. 249, č. - (2023), s. 114140
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36841007 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425140752 $b ABA008
999    __
$a ok $b bmc $g 1924363 $s 1189851
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 249 $c - $d 114140 $e 20230224 $i 1618-131X $m International journal of hygiene and environmental health $n Int J Hyg Environ Health $x MED00005700
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...